Lean biotech teams often assume supply will run smoothly. In global trials, fragmented ownership and poor visibility can quietly derail enrollment, timelines, and costs.
- Scaling Security And Speed In Last-Mile Cold Chain Delivery For Clinical Trials
- Green Supply Chains Rarely Start With A Pledge; Target Waste Instead
- The Firefighting Era Of Clinical Supply Chain Is Over. Here's What Replaces It
- Navigating FDA Inspections: Practical Steps For Clinical Supply Leaders, Part 2
- Regulatory Readiness In Clinical Supply: Building A Culture Of Compliance, Part 1
- Optimizing Clinical Trial Supply Chains For Epidemic Response
- The High Cost Of Zero Waste: Protecting Patients In Clinical Supply
- From Crisis Response To Repeatable Resilience In Clinical Supply
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Quality Assured: Bringing Life-Changing Therapies To Patients
Biopharmaceutical drug development remains a key trend, demanding specific expertise and capabilities when it comes to quality assurance. Explore four trends that matter in biologics for clinical trial supply.
-
Is Your Clinical Supply Chain Fully Optimized?
Streamlined supply chain operations alleviate staff workload and significantly reduce IP waste. With the right partners, you can create a fully optimized, cost-effective supply chain strategy.
-
How To Evaluate A Clinical Supply Chain Partner To Meet Vaccine Trial Needs
When selecting a supply chain partner, due diligence is critical. This article highlights questions you should be asking to ensure you are selecting the right supply chain partner for your clinical trial needs.
-
Providing Drug Supply Support In Complex Environments Through IRT
Learn how applying predictive data analytics can enable the creation of an ideal supply strategy capable of reducing the need for extra shipments, manual oversight, and supply waste.
-
Finding The Optimal IRT/RTSM Design For Your Clinical Trial
Determine the best IRT/RTSM design for your trial through consideration of the user, data collection, and future-proofing.
-
Managing Clinical Trial Supply Challenges In Complex Studies
Complex studies require flexible supply strategies that can adjust to shifting timelines, varied modalities, and global site needs. Adaptive, scalable planning helps lower risk.
-
How A Biotech Startup Transformed Their Clinical Trial Supply Management
Don’t let your trial get lost in the shuffle of legacy vendors. See how a high-touch, consultative approach can protect your study’s future.
-
Navigating New EU Clinical Trials Regulation Requirements For Clinical Supplies
Better understand Clinical Trials Regulation No. 536/201 (CTR) labeling changes and their potential to disrupt traditional clinical supply strategy that adhere to the new requirements.
-
When Protocol Amendments Meet RTSM: From Headache To High-Performance
Learn why an RTSM solution should be adaptive and flexible, and should help clinical trial teams uncover the best ways to handle protocol amendments.
-
Distributing Clinical Supply In The EU For Compassionate Use Programs
Explore the logistical and distribution risk management factors that need to be considered when planning an EU Compassionate Use Program, especially when faced with COVID-19 closures and challenges.
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.